Abstract

The purpose of this project is to create and implement a high-risk multi-drug resistant pneumonia pathway, based upon guidelines from the Infectious Disease Society of America and the American Thoracic Society 2005/2016 guidelines. The goal is to improve 30-day readmission rates and length of stay.

Description

44th Biennial Convention 2017 Theme: Influence Through Action: Advancing Global Health, Nursing, and Midwifery.

Authors

Linda Reynolds

Author Details

Linda Reynolds, MSN, nursing, DeSales University, Center Valley, Pennsylvania, USA

Sigma Membership

Mu Omicron

Lead Author Affiliation

DeSales University, Center Valley, Pennsylvania, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Healthcare Associated Pneumonia, Multi-drug Resistant Pneumonia, Multi-drug Resistant Risk Factors

Conference Name

44th Biennial Convention

Conference Host

Sigma Theta Tau International

Conference Location

Indianapolis, Indiana, USA

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (257 kB)

Share

COinS
 

Multidrug-resistant pneumonia: A clinical pathway from diagnosis to resolution

Indianapolis, Indiana, USA

The purpose of this project is to create and implement a high-risk multi-drug resistant pneumonia pathway, based upon guidelines from the Infectious Disease Society of America and the American Thoracic Society 2005/2016 guidelines. The goal is to improve 30-day readmission rates and length of stay.